Kiora Pharmaceuticals Inc (KPRX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $5.44M
Last updated: Nov 17, 2026 at 11:04 AM ET
Kiora Pharmaceuticals Inc (KPRX) Earnings: Report Dates and Results
Kiora Pharmaceuticals (KPRX) is expected to report earnings on Mar 23, 2027. In the quarter ended Sep 30, 2026, Kiora Pharmaceuticals reported EPS of -$0.28, above the -$0.38 estimate. It beat the EPS estimate in 6 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
KPRX has an expected report date of Mar 23, 2027.
Earnings History
Of the 39 quarters below that had an estimate, KPRX beat 27, missed 11 and matched 1. The widest gap in the table came in the quarter ended Dec 31, 2025, when EPS landed 293.70% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.28 | -$0.38 | -$0.38 - -$0.38 | +26.32% | Beat | -2900.0% | 1 | 1 up, 0 down | Nov 12, 2026 | $1.00M |
| Jun 30, 2026 | -$0.34 | -$0.62 | -$0.62 - -$0.62 | +45.16% | Beat | N/A | 1 | 1 up, 0 down | Aug 7, 2026 | N/A |
| Mar 31, 2026 | -$0.58 | -$0.71 | -$0.71 - -$0.71 | +18.31% | Beat | N/A | 1 | 0 up, 1 down | May 8, 2026 | N/A |
| Dec 31, 2025 | -$1.73 | -$0.44 | -$0.44 - -$0.44 | -293.70% | Miss | N/A | 1 | 0 up, 1 down | Mar 25, 2026 | N/A |
| Sep 30, 2025 | $0.01 | -$0.72 | -$0.72 - -$0.72 | +101.39% | Beat | N/A | 1 | 0 up, 1 down | Nov 7, 2025 | N/A |
| Jun 30, 2025 | -$0.54 | -$0.58 | -$0.58 - -$0.58 | +6.90% | Beat | N/A | 1 | 1 up, 0 down | Aug 8, 2025 | N/A |
| Mar 31, 2025 | -$0.52 | -$0.77 | -$0.77 - -$0.77 | +32.47% | Beat | -115.2% | 1 | 0 up, 1 down | May 9, 2025 | N/A |
| Dec 31, 2024 | -$1.21 | -$0.74 | N/A | -63.19% | Miss | N/A | 3 | 0 up, 0 down | Mar 25, 2025 | N/A |
| Sep 30, 2024 | -$0.81 | -$0.81 | -$0.90 - -$0.66 | 0.00% | In line | N/A | 3 | 0 up, 0 down | Nov 8, 2024 | N/A |
| Jun 30, 2024 | -$0.53 | -$0.88 | -$0.95 - -$0.81 | +39.77% | Beat | N/A | 3 | 0 up, 0 down | Aug 9, 2024 | $20000 |
| Mar 31, 2024 | $3.42 | $2.48 | N/A | +37.90% | Beat | N/A | 1 | 0 up, 0 down | May 10, 2024 | $16.00M |
| Dec 31, 2023 | -$0.47 | -$0.42 | -$0.48 - -$0.36 | -11.90% | Miss | N/A | 2 | 0 up, 0 down | Mar 28, 2024 | $283872 |
| Sep 30, 2023 | -$8.01 | -$3.10 | -$3.51 - -$2.70 | -158.39% | Miss | N/A | 3 | 0 up, 0 down | Nov 9, 2023 | N/A |
| Jun 30, 2023 | -$7.11 | -$9.59 | -$14.58 - -$4.59 | +25.86% | Beat | N/A | 2 | 0 up, 0 down | Aug 8, 2023 | N/A |
| Mar 31, 2023 | -$9.00 | -$20.34 | N/A | +55.75% | Beat | N/A | 2 | 0 up, 0 down | May 9, 2023 | N/A |
| Dec 31, 2022 | -$1.76 | -$2.46 | -$2.91 - -$2.17 | +28.46% | Beat | N/A | 3 | 0 up, 0 down | Mar 23, 2023 | N/A |
| Sep 30, 2022 | -$39.18 | -$25.83 | -$43.20 - -$25.83 | -51.68% | Miss | N/A | 2 | 0 up, 0 down | Nov 9, 2022 | N/A |
| Jun 30, 2022 | -$64.80 | -$72.00 | N/A | +10.00% | Beat | N/A | 1 | 1 up, 0 down | Jul 8, 2022 | N/A |
| Mar 31, 2022 | -$43.20 | -$82.80 | N/A | +47.83% | Beat | N/A | 2 | 0 up, 0 down | Apr 15, 2022 | N/A |
| Dec 31, 2021 | -$0.66 | -$0.30 | N/A | -120.00% | Miss | N/A | 1 | 0 up, 0 down | Mar 2, 2022 | N/A |
| Sep 30, 2021 | -$104.40 | -$121.20 | -$140.41 - -$104.41 | +13.86% | Beat | N/A | 3 | N/A | Nov 15, 2021 | N/A |
| Jun 30, 2021 | -$126.00 | -$150.00 | N/A | +16.00% | Beat | N/A | N/A | N/A | Aug 12, 2021 | N/A |
| Mar 31, 2021 | -$133.20 | -$138.60 | N/A | +3.90% | Beat | N/A | N/A | N/A | May 12, 2021 | N/A |
| Dec 31, 2020 | -$20.80 | -$17.60 | N/A | -18.18% | Miss | N/A | N/A | N/A | Mar 25, 2021 | $12059 |
| Sep 30, 2020 | -$158.40 | -$151.20 | N/A | -4.76% | Miss | N/A | N/A | N/A | Nov 9, 2020 | N/A |
| Jun 30, 2020 | -$136.80 | -$154.80 | N/A | +11.63% | Beat | N/A | N/A | N/A | Aug 6, 2020 | N/A |
| Mar 31, 2020 | -$0.43 | N/A | N/A | N/A | N/A | -100.8% | N/A | N/A | May 6, 2020 | N/A |
| Dec 31, 2019 | -$273.60 | -$291.60 | N/A | +6.17% | Beat | N/A | N/A | N/A | Mar 4, 2020 | N/A |
| Sep 30, 2019 | -$414.00 | -$270.00 | N/A | -53.33% | Miss | N/A | N/A | N/A | Nov 7, 2019 | N/A |
| Jun 30, 2019 | -$216.00 | -$270.00 | N/A | +20.00% | Beat | N/A | N/A | N/A | Aug 8, 2019 | N/A |
| Mar 31, 2019 | $54.00 | -$270.00 | N/A | +120.00% | Beat | N/A | N/A | N/A | May 8, 2019 | $2.69M |
| Dec 31, 2018 | -$30.00 | -$36.00 | N/A | +16.67% | Beat | N/A | N/A | N/A | Mar 1, 2019 | N/A |
| Sep 30, 2018 | -$378.00 | -$405.00 | N/A | +6.67% | Beat | N/A | N/A | N/A | Nov 13, 2018 | $314500 |
| Jun 30, 2018 | -$378.00 | -$702.00 | N/A | +46.15% | Beat | N/A | N/A | N/A | Aug 3, 2018 | $242012 |
| Mar 31, 2018 | -$756.00 | -$1,269.00 | N/A | +40.43% | Beat | N/A | N/A | N/A | May 11, 2018 | $1.10M |
| Dec 31, 2017 | -$90.00 | -$144.00 | N/A | +37.50% | Beat | N/A | N/A | N/A | Mar 2, 2018 | N/A |
| Sep 30, 2017 | -$1,296.00 | -$1,170.00 | N/A | -10.77% | Miss | N/A | N/A | N/A | Nov 14, 2017 | $74696 |
| Jun 30, 2017 | -$1,512.00 | -$1,044.00 | N/A | -44.83% | Miss | N/A | N/A | N/A | Aug 4, 2017 | $148290 |
| Mar 31, 2017 | -$1,512.00 | -$1,962.00 | N/A | +22.94% | Beat | N/A | N/A | N/A | May 5, 2017 | $184532 |
| Dec 31, 2016 | -$228.00 | -$254.00 | N/A | +10.24% | Beat | N/A | N/A | N/A | Feb 23, 2017 | $160370 |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$2.78, after $0.87 the year before. It was -$4,842.00 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$2.78 | -418.9% |
| Dec 31, 2024 | $0.87 | N/A |
| Dec 31, 2023 | -$24.59 | N/A |
| Dec 31, 2022 | -$148.94 | N/A |
| Dec 31, 2021 | -$364.26 | N/A |
| Dec 31, 2020 | -$316.43 | N/A |
| Dec 31, 2019 | -$849.60 | N/A |
| Dec 31, 2018 | -$1,542.00 | N/A |
| Dec 31, 2017 | -$4,410.00 | N/A |
| Dec 31, 2016 | -$4,842.00 | N/A |
Frequently Asked Questions About KPRX
When is Kiora Pharmaceuticals's next earnings date?
Kiora Pharmaceuticals's next earnings report is expected for Mar 23, 2027.
Did KPRX beat earnings estimates last quarter?
Yes. Kiora Pharmaceuticals reported EPS of -$0.28 for the quarter ended Sep 30, 2026, above the -$0.38 estimate, a 26.32% surprise.
What EPS do analysts expect from KPRX next quarter?
The consensus EPS estimate for Kiora Pharmaceuticals for the quarter ending Dec 31, 2026 is -$0.43 from 3 analysts.
How often does KPRX beat earnings estimates?
Kiora Pharmaceuticals beat the EPS estimate in 6 of the last 8 quarters, with an average surprise of -15.79%.
KPRX pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors